Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Bioprocess Simulations Gain Traction
Solutions for Dealing with Variability and Bottlenecks are Among the Benefits
- Bioprocessing simulations are gaining traction and sophistication in the biotech industry. Long a standard in other industries, “simulations are becoming requirements for all major design, construction, and de-bottlenecking projects,” according to Demetri Petrides, Ph.D., CEO, Intelligen (www.intelligen.com). Bioprocess simulations were generally run by chemical engineers. Biologists and microbiologists, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.